SOME patients taking part in phase 1 trials of Solbec Pharmaceuticals anti-cancer drug SBP002 have asked to continue taking the drug.
14/09/2004 - 22:00
Solbec patients want another dose
14/09/2004 - 22:00

SOME patients taking part in phase 1 trials of Solbec Pharmaceuticals anti-cancer drug SBP002 have asked to continue taking the drug.